Skip to main content

Table 3 Characteristics of the study population

From: Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study

Characteristic

Boys

Girls

Total

n (%)

n (%)

N (%)

Population 0–11 yr

3,188,004

3,073,468

6,261,472

Indigenous Dutch

2,292,021 (71.9)

2,189,282 (71.2)

4,481,303 (71.6)

1st generation immigrant

306,934 (9.6)

322,167 (10.5)

629,101 (10.0)

2nd generation immigrant

589,049 (18.5)

562,019 (18.3)

1,151,068 (18.4)

Deaths

7,924

6,114

14,038

0-1 monthsa

4,713 (59.9)

3,688 (60.3)

8,401 (59.8)

2-13 monthsb

1,143 (14.4)

870 (14.2)

2,013 (14.3)

14 months – 3 yearsc

902 (11.4)

671 (11.0)

1,573 (11.2)

4-8 yearsd

766 (9.7)

557 (9.1)

1,323 (9.4)

9-11 yearse

400 (5.0)

328 (5.4)

728 (5.2)

Primary cause of death

   

Unknown

128 (1.6)

122 (2.0)

250 (1.8)

Infectious and parasitic diseases

203 (2.6)

171 (2.8)

374 (2.7)

Neoplasms

512 (6.5)

393 (6.4)

905 (6.4)

Diseases of the blood and blood forming organs and certain disorders involving the immune mechanism

53 (0.7)

46 (0.8)

99 (0.7)

Endocrine, nutritional and metabolic diseases

196 (2.5)

148 (2.4)

344 (2.5)

Mental and behavioural disorders

23 (0.3)

19 (0.3)

42 (0.3)

Diseases of the nervous system

383 (4.8)

337 (5.5)

720 (5.1)

Diseases of the circulatory system

176 (2.2)

134 (2.2)

310 (2.2)

Diseases of the respiratory system

162 (2.0)

125 (2.0)

287 (2.0)

Diseases of the digestive system and the genitourinary system

99 (1.2)

61 (1.0)

160 (1.1)

Diseases of the skin, subcutaneous tissue, musculoskeletal system and connective tissue

13 (0.2)

17 (0.3)

30 (0.2)

Complications of the pregnancy, childbirth and the puerperium and conditions originating in the perinatal period

2,973 (37.5)

2,192 (35.9)

5,165 (36.8)

Congenital anomalies

1,926 (24.3)

1,630 (26.7)

3,556 (25.3)

Symptoms, signs and ill-defined conditions

426 (5.4)

332 (5.4)

758 (5.4)

External causes of injury and poisoning

651 (8.2)

387 (6.3)

1,038 (7.4)

  1. aMost recent vaccination: none.
  2. bMost recent vaccinations: DTaP(−HBV)-IPV/Hib and pneumococcal vaccination.
  3. cMost recent vaccinations: MMR and meningococcal C vaccination (only after September 2002).
  4. dMost recent vaccination: DTaP-IPV booster vaccination.
  5. eMost recent vaccinations: DT-IPV booster and MMR booster vaccination.